Skip to product information
1 of 1

Alkixen 250mg capsule (crizotinib)

Alkixen 250mg capsule (crizotinib)

View full details
Packaging Size: 30 capsules (1 × 30)
Strength: 250 mg
Composition: Crizotinib 250 mg per capsule
Treatment: ALK-positive or ROS1-positive advanced/metastatic non-small-cell lung cancer (NSCLC); crizotinib is a targeted kinase inhibitor.
Form: Hard gelatin capsule
Brand: Alkixen
Quantity Unit: 1 capsule
Manufacturer: Everest Pharmaceuticals Ltd

Alkixen 250 mg (crizotinib) is an oral targeted cancer medicine called a kinase inhibitor. It blocks abnormal ALK and ROS1 signaling, which can slow or stop the growth of certain cancer cells. It is used mainly for ALK-positive or ROS1-positive non-small-cell lung cancer (NSCLC) and, in certain patients, other ALK-positive cancers.

  • Usual adult dose for metastatic NSCLC: 250 mg twice daily, although the dose may be adjusted by a doctor.
  • Common side effects: nausea, diarrhea, vomiting, constipation, vision disturbances, swelling, fatigue, and changes in liver enzymes.
  • Important risks: liver toxicity, lung inflammation/pneumonitis, heart rhythm changes, slow heart rate, and serious vision problems.

It should be taken only under an oncologist's supervision, with appropriate testing to confirm the cancer's target (such as ALK or ROS1 positivity).

Everyone Deserves Access to Life-saving Treatment Of Cancer. We are a Trusted Cancer Medicine seller delivering certified medications to every corner of the world.